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Expiratory flow limitation is associated with dynamic hyperinflafion & 
chronic dyspnoea in adult cysfic fibrosis 
A.E. Holland 14, L. Denehy 4, J.W. Wilson 23 
~Departments of Physiotherapy & ~AIIergy, Immu~u~logy & Respiratory Medicine, 
Alfred Hospital; 3Department of Medicine, Motw~sh University; & 4School of 
Physiotherapy, University of Melbourne, Victoria, Australia. 
Aim: Tidal expiratory flow l imitation may promote dynamic hyper hfflation & play 
a role in the pathogenesis of cbr onic dyspnoea. The aim of this study was to evaluate 
the prevalence of expiratory flow l imitation (EFL) ha adult cystic fibrosis (CF). 
Methods: The presence of EFL was evaluated ha 102 adults with stable CF (FEV 1 
range 17.3 91.5 %pred) & 20 control subjects with the Negative Expiratory 
Pressure (NEP) technique. Subjects were classified as not flow l imited (non FL), 
f low l imited ha supine (FLSupine) or f low l imited ha sitting & supine (FLSeated). 
Inspiratory capacity (IC) was measured ha sitting & supine, & cbronic dyspnoea 
evaluated using the modified Medical  Research Council (MRC) scale. Results: 
Expiratory f low l imitation was present in 34 subjects with CF (33.3 %). Sixteen 
subjects (15.7%) were FL Supine & 18 subjects (17.6%) were FLSeated. FEV 1 was 
lower ha FLSeated subjects (mean FEV 1 28.5% pred, 95%CI 24.9 32.0 %pred) 
compared to FLSupine subjects (40.5, 34.8M6.1%pred)  & nonFL  CF subjects 
(57.3, 53 .(~61.0 %pred). Inspiratory capacity in sitting was reduced in FLSeated 
subjects (p~).03) whilst IC in supine was reduced ha both FLSeated (p 0.CO1) & 
FL Supine subjects (p 0.03) compared to nonFL  CF subjects. IC was also reduced 
in non FL CF s~abject s compared to the control group. FLSeated subjects reported 
higher MRC scores (2.2, 1.8 2.7) than either FLSupine (1.4, 1.1 1.7) or non FL CF 
subjects (1.0, .9 1.2). Conclusions: Tidal EFL in CF is associated with severe lung 
disease & dynamic hyperilfflation. Flow l imitation in sitting is associated with 
increased levels of chronic dyspnoea. 
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Non invasive negative biphasic cuirass venfilator as a bridge to Lung 
transplant in Cysfic Fibrosis 
D. Shoseyov 1, D. Lint on 1, M.R. Kr amer 2, E. Kerem 1 
~CF Center Hadassah University Hospital, Jerusalem, Israel. 2pulmonary Institute, 
Rabin Medical Center; Beilinson Campus Petal* ~lav  Israel 
Cystic fibrosis (CF) is associated with cbronic progressive lung illness. Respiratory 
fai lure develops and patients become ventilator <lependent unti l  lung transplantation 
is available. B i  Phasic Cuirass Ventilation (BPCV) is a form of non invasive 
respiratory support which can provide high frequency chest wal l  oscillations in 
addition to negative pressure ventilation. The patients can cough, talk, eat mad 
therefore have a better quality of l ife compared to those receiving BiPAP 
ventilation. We present 3 CF patients with respiratory fai lure who were await ing 
lung transplantation. Patient 1, a 20 year old male, was on a positive pressure 
ventilator via tracheostomy on arrival to our center. Several weeks after the 
initiation of treatment with BPCV, he was decannulated, had a lower oxygen 
requirement, gained weight, and the arterial PaCO 2 decreased. Two months later he 
had a successful ung transplant. Patient 2, a 13 year old female, had severe 
respiratory deterioration and an increased oxygen requirement. Her FEV 1 was 12% 
of predicted. One month after starting treatment BPCV treatment, her FEV 1 
increased to 25 %, and FiO 2 was decreased. Her weight increased from 29 Kg to 40 
Kg and she does not retain CO 2. Patient 3, an 18 year old male, gradually 
deteriorated torespiratory failure. As a result of treatment with the BPCV in the last 
3 months, he is ha stable condition, and his PaCO 2 has normalized. Both of them are 
still await ing lung transplant .In conclusion, the BPCV is an effective device ha CF 
patients with respiratory fai lure await ing lung transplantation. It is comfortable, 
facilitates mucous clearance, and is associated with improved nutrition and a 
reduction of PaCO 2. 
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Survival and prognosis after assisted ventilation for acute respiratory 
failure in cysfic fibrosis 
M.G. Slieker 1, J.P.J. van Gestel ~, G.A. Tr ampe rl, F. Teding van Bet khout 1, H.G.M. 
Hei jer man 3, C.K. van der Ent 1, N. J .G Jansen 2
~CF Center Utrecht a~ul 2pediatric Intensive Care Unit, UMC U recht, Utrecht, 
Netherlands, 3Adult CF Center; Haga Hospital, the Hague, Netherlands 
Aims: To assess outcome of assisted ventilation (AV) in cystic fibrosis (CF) patients 
with acute respiratory fai lure (ARF), to identify r isk factors associated with poor 
outcome and to analyze it" patients with CF who required AV for ARF in childhood 
had a worse prognosis compared with unventi lated CF controls. 
Methods: A retrospective cohort study was conducted of CF patients who required 
AV for ARF. Outcome of AV and potential r isk factors for poor outcome were 
recorded. In patients who had an episode of ARF in childhood, lung function mad 
development of CF related complications 5 years after AV were also measured. 
Results: Thirty4wo CF patients required AV for ARF between 1990 and 2CO3. Al l  
5 children and 8 of the 27 adult patients (30%) survived their episode of ARF. In the 
total population of pediatric and adult patients, age was a statistically significant 
r isk factor for poor outcome (P 0.03). In the adult population, none of the 
demographic and clinical data could significantly predict outcome. In patients who 
had an episode of ARF in childhood, lung function mad presence of CF related 
complications 5 years after AV were not significantly different compared with non 
ventilated controls. 
Conclusions: CF patients aged two years and younger who are ventilated because 
of ARF have an excellent prognosis and AV does not seem to affect lung function 
or development of CF related complications later in life. On the other hand, ARF ha 
adult CF patients is still associated with a high mortality. Risk factors for poor 
outcome could not be identified. 
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Heart-lung transplantation (HLT) in cysfic fibrosis patients (CF). 
A single cenke 18yr experience 
K.M. Gyi I , M.E. Hodson 1, M.H. Yacoub 2 
iDept of Cystic Fibrosis, Royal Brompton Hospital, London SW3 6N, 2Ha@eM 
Hospital, Uxbridge, Middlese~ UB9 6JH, UK 
Background: The experience of 165 CF patients who underwent HLT between 
1984 2001 at our centre was reviewed. 165 CF patients (73 female) with end stage 
lung disease underwent HLT. Mean age was 25(range 10 52 yrs). At l isting mean 
FEV 1 was 20%, PaCO~ 7.1 kPa, PaO~ 6.8kPa, and BMI  17. H igh  r isk included 
B.cepacia (12), pan resistant pseudomonas (12), MRSA airway colonisation (3), 
aspergil loma (2), conventional ventilation (5), non invasive positive pressure 
ventilation (27), prior pleural intervention (18) and portal hypertension (4). 
Results: survival was 70% at lyr, 53% at 5yrs, 40% at 10yrs, and 33% at 15yrs. 32 
survived more than 10yrs with longest survivor at 16.2yrs post transplant. Survival 
was significantly lower in B.cepacia and conventionally ventilated patients. Talc 
pleur odesis and total pleurect amy was associated with increased hospital mortality. 
Recipients with pre4ransplant NIPPV, pan~esistant pseudomonas and MRSA 
colonisation had no survival disadvantage. Combination of r isk factors has more 
impact on mortal ity than a single r isk factor. 17 patients underwent re 
transplantation with survival of 42% at lyr. 62 developed bronchiolitis obliterans 
syndrome (BOS) with overall incidence of 47%. 8 developed post transplant 
lymphopr olifer ative disease. Significant graft coronary artery disease occurred in 2. 
20 patients required cbronic dialysis and 6 had renal transplant. Major causes of 
mortality were infection and BOS. Lung function improved to FEV 1 of 81% at lyr,  
83% at 10 yrs. 61% of the current survivors are in ful l  or part t ime employment or 
education. 
Conclusion: HLT CF patients can achieve prolonged s~arvival with good graft 
function. Successful outcome is also possible in some high risk patients 
